GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acrux Ltd (FRA:FJY) » Definitions » 3-Year EPS without NRI Growth Rate

Acrux (FRA:FJY) 3-Year EPS without NRI Growth Rate : 67.30% (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Acrux 3-Year EPS without NRI Growth Rate?

Acrux's EPS without NRI for the six months ended in Dec. 2023 was €-0.01.

During the past 3 years, the average EPS without NRI Growth Rate was 67.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 39.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Acrux was 67.30% per year. The lowest was -47.30% per year. And the median was -0.20% per year.


Competitive Comparison of Acrux's 3-Year EPS without NRI Growth Rate

For the Biotechnology subindustry, Acrux's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acrux's 3-Year EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acrux's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Acrux's 3-Year EPS without NRI Growth Rate falls into.



Acrux 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Acrux  (FRA:FJY) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Acrux 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Acrux's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Acrux (FRA:FJY) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acrux Ltd (FRA:FJY) » Definitions » 3-Year EPS without NRI Growth Rate
Traded in Other Exchanges
Address
103-113 Stanley Street, West Melbourne, Melbourne, VIC, AUS, 3003
Acrux Ltd is a pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. The group is formulating and developing a range of topical generic products by leveraging its skilled workforce, on-site laboratories, GMP manufacturing suite, and technical, clinical, and commercial experience to bring affordable products to market. Geographically, it has a presence in Australia; the United States; Europe, and other countries. The firm operates in a single segment and derives revenue from developing and commercializing pharmaceutical products that administer drugs topically. Its product pipeline products include Lenzetto, Evamist, Testosterone Topical Solution, and among others.

Acrux (FRA:FJY) Headlines

No Headlines